Skip to main content
Caplight Logo









NAYO Biotechnology

NAYO Biotechnology

Private
ShanghaiHealthcare & Life Scienceshttps://www.nayolab.com/

Last Round

Series A

Jun 1, 2022

Company Overview

NAYO Biotechnology operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in June 2022.

NAYO Biotechnology is a life sciences company that develops and manufactures automated laboratory instruments, including liquid handling platforms and integrated systems for clinical diagnostics and research.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Workflow Automation, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

NAYO Biotechnology Comparables

Compare NAYO Biotechnology with similar companies based on industry and business-model similarity.

NAYO Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PRCXI Bioinformatics Co., Ltd.
90%
Tiangen Biotech (Beijing) Co., Ltd.
80%
Ashmar Scientific (Shanghai) Co., Ltd.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

NAYO Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 459% MoM.

  • Sep 1, 2025

    Grew 57% QoQ from 7 to 11 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

NAYO Biotechnology Filings

Explore SEC and related filing metadata, where available.

NAYO Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about NAYO Biotechnology's valuation, stock price, and market status.

Is NAYO Biotechnology a public or private company?

NAYO Biotechnology is a private company.

What is the current stock price of NAYO Biotechnology?

NAYO Biotechnology is a private company, so its shares have no public market price. Caplight tracks NAYO Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NAYO Biotechnology worth (valuation)?

Valuation information for NAYO Biotechnology is not publicly available.

Can I buy NAYO Biotechnology stock?

NAYO Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NAYO Biotechnology's last funding round?

NAYO Biotechnology's most recent funding round was Series A on June 1, 2022.

Who are the main investors in NAYO Biotechnology?

Investor information for NAYO Biotechnology is not publicly disclosed.

Will NAYO Biotechnology IPO soon?

No public IPO plans have been announced for NAYO Biotechnology.

How can I track NAYO Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades in NAYO Biotechnology's shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Employee Range14
Year Founded2015
Last FundingJun 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?